52w high/low | ₹3298.5 / ₹2311.1 |
P/E ratio | 68.85 |
Dividend | 0.84 |
ROE | 21.74 |
ROCE | 25.26 |
Face value | 5 |
Book value | ₹222.39Cr |
Market capital | ₹1,12,638.04Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Torrent Pharmaceuticals is one of the leading pharmaceutical companies having presence in Indian and global markets. The company is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS). The company also has significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. The company has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million. Torrent Pharma is 6th largest pharma company in India in terms of Enterprise Value. It is ranked 8th in the Indian Pharmaceuticals Market and is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), and Vitamins Minerals Nutritionals (VMN). Torrent Pharma has a strong international presence spread across 40 countries with operations in regulated and emerging markets like US, Europe, Brazil and Rest of the World. The company operates through its wholly owned subsidiaries spread across 12 nations with major setups in Brazil, Germany and US.